• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

III 型分泌系统小分子抑制剂的研究进展。

Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System.

机构信息

School of Chemistry and Chemical Engineering, Dezhou University, Dezhou 253023, China.

School of Life Sciences, Dezhou University, Dezhou 253023, China.

出版信息

Molecules. 2022 Nov 30;27(23):8348. doi: 10.3390/molecules27238348.

DOI:10.3390/molecules27238348
PMID:36500441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9740592/
Abstract

The overuse of antibiotics has led to severe bacterial drug resistance. Blocking pathogen virulence devices is a highly effective approach to combating bacterial resistance worldwide. Type three secretion systems (T3SSs) are significant virulence factors in Gram-negative pathogens. Inhibition of these systems can effectively weaken infection whilst having no significant effect on bacterial growth. Therefore, T3SS inhibitors may be a powerful weapon against resistance in Gram-negative bacteria, and there has been increasing interest in the research and development of T3SS inhibitors. This review outlines several reported small-molecule inhibitors of the T3SS, covering those of synthetic and natural origin, including their sources, structures, and mechanisms of action.

摘要

抗生素的过度使用导致了严重的细菌耐药性。阻断病原体毒力装置是全球对抗细菌耐药性的一种非常有效的方法。III 型分泌系统(T3SS)是革兰氏阴性病原体的重要毒力因子。抑制这些系统可以有效地削弱感染,而对细菌生长没有显著影响。因此,T3SS 抑制剂可能是对抗革兰氏阴性菌耐药性的有力武器,人们对 T3SS 抑制剂的研究和开发越来越感兴趣。本文综述了几种已报道的 T3SS 的小分子抑制剂,包括合成和天然来源的抑制剂,涵盖了它们的来源、结构和作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/3420a80e14c8/molecules-27-08348-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/fbdfc42370fe/molecules-27-08348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/d0affcf353f4/molecules-27-08348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/900050d743d2/molecules-27-08348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/07a027d3c7b7/molecules-27-08348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/bbb12a5a8beb/molecules-27-08348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/ec73092f316d/molecules-27-08348-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/02505da52e46/molecules-27-08348-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/d06c2c9e854c/molecules-27-08348-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/34faac1685bb/molecules-27-08348-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/5a4d43feca36/molecules-27-08348-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/3ab60e1edf49/molecules-27-08348-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/faa054a4c91b/molecules-27-08348-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/a3924eb38d77/molecules-27-08348-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/2a7fda7d3394/molecules-27-08348-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/3420a80e14c8/molecules-27-08348-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/fbdfc42370fe/molecules-27-08348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/d0affcf353f4/molecules-27-08348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/900050d743d2/molecules-27-08348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/07a027d3c7b7/molecules-27-08348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/bbb12a5a8beb/molecules-27-08348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/ec73092f316d/molecules-27-08348-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/02505da52e46/molecules-27-08348-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/d06c2c9e854c/molecules-27-08348-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/34faac1685bb/molecules-27-08348-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/5a4d43feca36/molecules-27-08348-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/3ab60e1edf49/molecules-27-08348-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/faa054a4c91b/molecules-27-08348-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/a3924eb38d77/molecules-27-08348-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/2a7fda7d3394/molecules-27-08348-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9740592/3420a80e14c8/molecules-27-08348-g015.jpg

相似文献

1
Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System.III 型分泌系统小分子抑制剂的研究进展。
Molecules. 2022 Nov 30;27(23):8348. doi: 10.3390/molecules27238348.
2
Small-Molecule Inhibitors of the Type III Secretion System.III型分泌系统的小分子抑制剂
Molecules. 2015 Sep 23;20(9):17659-74. doi: 10.3390/molecules200917659.
3
Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli.微生物群和病原体蛋白酶调节肠出血性大肠杆菌中的 III 型分泌活性。
mBio. 2018 Dec 4;9(6):e02204-18. doi: 10.1128/mBio.02204-18.
4
Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components.抑制细菌 III 型分泌系统(T3SS)的分子靶点和策略;直接结合 T3SS 成分的抑制剂。
Biomolecules. 2021 Feb 19;11(2):316. doi: 10.3390/biom11020316.
5
The type III secretion system needle, tip, and translocon.III 型分泌系统的针、尖端和转位器。
Protein Sci. 2019 Sep;28(9):1582-1593. doi: 10.1002/pro.3682. Epub 2019 Aug 2.
6
Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria.开发环状缩肽作为革兰氏阴性菌中广谱 III 型分泌系统抑制剂。
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0169020. doi: 10.1128/AAC.01690-20.
7
Type III Secretion in the Melioidosis Pathogen .类鼻疽病菌中的III型分泌系统
Front Cell Infect Microbiol. 2017 Jun 15;7:255. doi: 10.3389/fcimb.2017.00255. eCollection 2017.
8
Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.作为抗生素替代品的毒力阻断剂:针对革兰氏阴性菌的III型分泌抑制剂
J Intern Med. 2008 Jul;264(1):17-29. doi: 10.1111/j.1365-2796.2008.01941.x. Epub 2008 Apr 3.
9
Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.三类分泌系统的化学抑制剂:瓦解细菌病原体。
Antimicrob Agents Chemother. 2012 Nov;56(11):5433-41. doi: 10.1128/AAC.00975-12. Epub 2012 Jul 30.
10
Shutting Down Shigella Secretion: Characterizing Small Molecule Type Three Secretion System ATPase Inhibitors.阻断志贺氏菌分泌:小分子三型分泌系统ATP酶抑制剂的特性研究
Biochemistry. 2018 Dec 18;57(50):6906-6916. doi: 10.1021/acs.biochem.8b01077. Epub 2018 Dec 5.

引用本文的文献

1
Antibiotics re-booted-time to kick back against drug resistance.抗生素迎来新契机——是时候反击耐药性了。
NPJ Antimicrob Resist. 2025 May 30;3(1):47. doi: 10.1038/s44259-025-00096-1.
2
Experimental Approaches to Visualize Effector Protein Translocation During Host-Pathogen Interactions.宿主-病原体相互作用期间可视化效应蛋白易位的实验方法
Bioessays. 2025 Apr;47(4):e202400188. doi: 10.1002/bies.202400188. Epub 2025 Mar 13.
3
Antibacterials with Novel Chemical Scaffolds in Clinical Development.处于临床开发阶段的具有新型化学骨架的抗菌药物。

本文引用的文献

1
A small molecule, CHClNOS, inhibits the function of the type III secretion system in Salmonella Typhimurium.一种小分子CHClNOS可抑制鼠伤寒沙门氏菌中III型分泌系统的功能。
J Genet Eng Biotechnol. 2022 Apr 5;20(1):54. doi: 10.1186/s43141-022-00336-1.
2
Tannic Acid Inhibits Serovar Typhimurium Infection by Targeting the Type III Secretion System.单宁酸通过靶向Ⅲ型分泌系统抑制鼠伤寒血清型沙门氏菌感染。
Front Microbiol. 2022 Jan 25;12:784926. doi: 10.3389/fmicb.2021.784926. eCollection 2021.
3
Biomedical applications of tannic acid.单宁酸的生物医学应用。
Drugs. 2025 Mar;85(3):293-323. doi: 10.1007/s40265-024-02137-x. Epub 2025 Jan 23.
4
A Review of Antibacterial Candidates with New Modes of Action.具有新型作用机制的抗菌候选药物综述。
ACS Infect Dis. 2024 Oct 11;10(10):3440-3474. doi: 10.1021/acsinfecdis.4c00218. Epub 2024 Jul 17.
5
Antibiotics in the clinical pipeline as of December 2022.截至 2022 年 12 月处于临床研发管线中的抗生素。
J Antibiot (Tokyo). 2023 Aug;76(8):431-473. doi: 10.1038/s41429-023-00629-8. Epub 2023 Jun 8.
J Biomater Appl. 2022 Mar;36(8):1503-1523. doi: 10.1177/08853282211058099. Epub 2022 Jan 7.
4
Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone.T3SS 抑制性卤代吡咯烷酮与 C-30 呋喃酮联合的抗病原体特性。
Molecules. 2021 Dec 16;26(24):7635. doi: 10.3390/molecules26247635.
5
Anti-Virulence Properties of Plant Species: Correlation between In Vitro Activity and Efficacy in a Murine Model of Bacterial Infection.植物物种的抗毒力特性:体外活性与细菌感染小鼠模型中疗效的相关性
Microorganisms. 2021 Nov 25;9(12):2424. doi: 10.3390/microorganisms9122424.
6
Synthesis and Biological Evaluation of 1,2,4-Triazole Thioethers as Both Potential Virulence Factor Inhibitors against Plant Bacterial Diseases and Agricultural Antiviral Agents against Tobacco Mosaic Virus Infections.1,2,4-三唑硫醚的合成及生物评价:作为植物细菌性病害潜在毒力因子抑制剂和防治烟草花叶病毒感染的农用抗病毒剂。
J Agric Food Chem. 2021 Dec 22;69(50):15108-15122. doi: 10.1021/acs.jafc.1c05202. Epub 2021 Dec 14.
7
Identification of Novel Type Three Secretion System (T3SS) Inhibitors by Computational Methods and Anti- Evaluations.通过计算方法和抗评估鉴定新型三型分泌系统(T3SS)抑制剂
Front Pharmacol. 2021 Nov 16;12:764191. doi: 10.3389/fphar.2021.764191. eCollection 2021.
8
Structural optimization of natural product fusaric acid to discover novel T3SS inhibitors of Salmonella.对天然产物镰刀菌酸进行结构优化以发现新型沙门氏菌III型分泌系统抑制剂。
Biochem Biophys Res Commun. 2021 Dec 10;582:72-76. doi: 10.1016/j.bbrc.2021.10.035. Epub 2021 Oct 18.
9
The Case against Antibiotics and for Anti-Virulence Therapeutics.反对使用抗生素而支持抗毒力疗法的理由。
Microorganisms. 2021 Sep 28;9(10):2049. doi: 10.3390/microorganisms9102049.
10
Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli.鉴定靶向肠致病性大肠杆菌 III 型分泌系统的易位抑制剂。
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0095821. doi: 10.1128/AAC.00958-21. Epub 2021 Sep 20.